Navigation Links
Sleeping Trojan horse to aid imaging of diseased cells
Date:2/17/2011

A unique strategy developed by researchers at Cardiff University is opening up new possibilities for improving medical imaging.

Medical imaging often requires getting unnatural materials such as metal ions into cells, a process which is a major challenge across a range of biomedical disciplines. One technique currently used is called the 'Trojan Horse' in which the drug or imaging agent is attached to something naturally taken up by cells.

The Cardiff team, made of researchers from the Schools of Chemistry and Biosciences, has taken the technique one step further with the development of a 'sleeping Trojan horse'. The first example of its kind, this is delivery system resolves some of the current difficulties involved in transporting metal ions into cells.

It is not itself taken up by cells so does not interfere with natural functions until it is 'woken' by the addition of the metal ions. This minimises the unwanted uptake and need for time-consuming purification associated with the common 'Trojan Horse' technique.

The research was led by Dr Mike Coogan, Senior Lecturer in Synthetic Chemistry, along with the paper's first author, Flora Thorp-Greenwood.

Dr Coogan said: "The sleeping Trojan horse process happens rapidly, and the vessel is capable of carrying metals which have positron-emitting isotopes, so it has potential for use in bimodal fluorescence and PET imaging. Combined agents for these types of imaging are known but rare, so this is a significant development in the field.

"There is also additional potential for use in radiotherapy as the metal-bearing form not only enters cells but also localises in the nucleolus. In principle, the concept could also be used to improve delivery of a huge range of drugs and imaging agents into cells or the body."

The study A 'Sleeping Trojan Horse' which transports metal ions into cells, localises in nucleoli, and has potential for bimodal fluorescence/PET imaging is published in the advanced article section of Chemical Communications. Published by the Royal Society of Chemistry, this is the leading weekly journal for the publication of important developments in the chemical sciences.


'/>"/>

Contact: Dr. Mike Coogan
cooganmp@cf.ac.uk
44-292-087-4066
Cardiff University
Source:Eurekalert

Related biology news :

1. Emotion and scent create lasting memories -- even in a sleeping brain
2. Dog owners more likely to share germs with pets by not washing hands than by sleeping with dog
3. Sleeping Beauty -- Molecule of the Year
4. Scientists hope to end sleeping sickness by making parasite that causes it self-destruct
5. Sleeping Beauty hooks up with herpes to fight brain disease
6. Biologists identify genes regulating sleeping and feeding
7. Trojan Horse attack on native lupine
8. Trojan Horse ploy to sneak protective drug into brains of stroke patients
9. Stem cell research to benefit horse owners and trainers
10. Queens University Belfast works to save Strangford horse mussels
11. Decline of shorebird linked to bait use of horseshoe crabs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
(Date:6/23/2016)... 23, 2016 ReportsnReports.com adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
Breaking Biology Technology: